• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Pharvaris N.V. (NQ: PHVS )

    20.35 -0.20 (-0.97%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 15, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Pharvaris N.V.

    < Previous 1 2 3 4 5 Next >
    Pharvaris Announces FDA Lifting of the Clinical Hold of Deucrictibant for the Prophylactic Treatment of HAE Attacks
    From Pharvaris N.V.
    Via GlobeNewswire
    Pharvaris Provides Business Update and Outlines 2024 Strategic Priorities
    From Pharvaris N.V.
    Via GlobeNewswire
    Pharvaris Presents Deucrictibant Clinical Data and Analysis of Endpoints for Trials of On-demand Treatment of HAE at the GA²LEN UCARE Conference 2023
    From Pharvaris N.V.
    Via GlobeNewswire
    Analyst Expectations for Pharvaris's Future
    Via Benzinga
    Gold Moves Higher; Campbell Soup Earnings Top Expectations
    U.S. stocks traded mixed toward the end of trading on Wednesday. The Dow traded up 0.05% to 36,143.40 while the NASDAQ fell 0.06% to 14,221.51. The S&P 500 also fell, dropping, 0.05% to 4,564.73. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results. 
    Via Benzinga
    Turnaround For Pharvaris Since FDA Clinical Hold - Data Shows Its Oral Hereditary Angioedema Treatment Cuts Attacks
    Pharvaris NV (NASDAQ: PHVS) released topline data from the CHAPTER-1 Phase 2 study meeting its primary endpoint, with deucrictibant demonstrating statistically significant and clinically meaningful... 
    Via Benzinga
    Exposures Product Safety
    Crude Oil Down 4%; Pharvaris Shares Spike Higher
    U.S. stocks traded mostly flat midway through trading, with the S&P 500 turning lower on Wednesday. The Dow traded up 0.01% to 36,126.75 while the NASDAQ rose 0.03% to 14,233.77. The S&P 500 also fell,... 
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    AMD Stock Alert: What to Expect From Advanced Micro Devices ‘Advancing AI’ Event
    Advanced Micro Devices stock is climbing higher on Wednesday as AMD investors prepare for the company's Advancing AI event today. 
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    THOR Industries Reports Upbeat Earnings, Joins Dave & Buster's Entertainment, Campbell Soup And Other Big Stocks Moving Higher On Wednesday
    U.S. stocks traded higher, with the Dow Jones index gaining more than 50 points on Wednesday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Shopify (SHOP) Stock Falls Following Analyst Downgrade
    Shopify stock is taking a beating on Wednesday after shares of SHOP were hit with a downgrade from Wedbush analyst Scott Devitt. 
    Via InvestorPlace
    Why Is Pharvaris (PHVS) Stock Up 36% Today?
    Pharvaris stock is rising higher on Wednesday following news of an underwritten offering for PHVS shares and pre-funded warrants. 
    Via InvestorPlace
    US Stocks Higher; Private Payrolls Rise By 103,000 In November
    U.S. stocks traded higher this morning, following the release of economic reports on Wednesday. Following the market opening Wednesday, the Dow traded up 0.21% to 36,200.86 while the NASDAQ rose 0.28%... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Pharvaris Announces Pricing of $300 Million Underwritten Offering of Ordinary Shares and Pre-funded Warrants
    From Pharvaris N.V.
    Via GlobeNewswire
    Pharvaris Announces Positive Top-line Phase 2 Data from the CHAPTER-1 Study of Deucrictibant for the Prophylactic Treatment of HAE Attacks
    From Pharvaris N.V.
    Via GlobeNewswire
    Pharvaris to Present at the GA²LEN UCARE Conference 2023
    From Pharvaris N.V.
    Via GlobeNewswire
    Pharvaris Appoints Stefan Abele, Ph.D., as Chief Technical Operations Officer
    From Pharvaris N.V.
    Via GlobeNewswire
    Pharvaris Presents Deucrictibant Clinical Data and Real-World HAE Treatment Satisfaction Data at ACAAI 2023 Annual Scientific Meeting
    From Pharvaris N.V.
    Via GlobeNewswire
    Pharvaris Reports Third Quarter 2023 Financial Results and Provides Business Update
    From Pharvaris N.V.
    Via GlobeNewswire
    Pharvaris To Present at the ACAAI 2023 Annual Scientific Meeting
    From Pharvaris N.V.
    Via GlobeNewswire
    Pharvaris To Present at the APAAACI 2023 International Conference
    From Pharvaris N.V.
    Via GlobeNewswire
    Pharvaris To Present at the CIIC Fall 2023 Conference
    From Pharvaris N.V.
    Via GlobeNewswire
    Pharvaris' Promising Oral Treatment Solutions For Treating Swollen Blood Vessels - Analyst Sees 35% Upside
    Wedbush has initiated coverage on Pharvaris N.V. (NASDAQ: PHVS), noting that the company stands out as one of the players with their strategy to develop and advance oral therapeutic options in both the... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
    Via Benzinga
    Pharvaris To Participate in the 2023 Cantor Global Healthcare Conference
    From Pharvaris N.V.
    Via GlobeNewswire
    Smucker, FuelCell Energy, Granite Ridge Resources And Other Big Stocks Moving Lower On Monday
    U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Monday. Here are some big stocks recording losses in today’s session. IHS Holding Limited (NYSE: IHS) shares fell 15.7% to... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Pharvaris To Present at the 18th German Allergy Congress
    From Pharvaris N.V.
    Via GlobeNewswire
    Pharvaris To Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
    From Pharvaris N.V.
    Via GlobeNewswire
    Pharvaris To Present at the 2023 HAEi Regional Conference EMEA
    From Pharvaris N.V.
    Via GlobeNewswire
    Farfetch, Faraday Future Intelligent Electric, VinFast, And Other Stocks Moving Lower On Friday
    U.S. stocks traded down this morning, with the Nasdaq Composite falling more than 101 points on Friday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    < Previous 1 2 3 4 5 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.